+1 actually

Find more information about Teva in your location, or contact a local representative on our country sites

North America

International Markets

Europe

North America

International Markets

Europe

alt text

News & Media

Take a look inside our world

alt text

Mount Sinai Publishes New Research Highlighting Novel Method to Identify Patterns Among Patients wit...

alt text

HIV Awareness: A Look at the Facts

alt text

Antibiotics Aren’t Always the Solution

alt text

Teva Announces Early Tender Results of its Debt Tender Offer and Election of Early Settlement

alt text

Teva and the Weizmann Institute of Science enter into collaboration to identify the next generation ...

alt text

Teva and Tel Aviv University sign a collaboration agreement for innovative R&D in the fields of canc...

alt text

Christoph Stoller Appointed as new President of Medicines for Europe

alt text

Saving Billions While Fueling Economies: Teva’s First-Ever Global Economic Impact Report

alt text

All Feature Stories

alt text

All Press Releases

alt text

Connect with us on social media

View Teva’s Social Guidelines

Follow us

Facebook |

Contacts for Media Inquiries

Kelley Dougherty

Corporate Communications North America

+1-973-658-0237

Kelley.Dougherty@tevapharm.com

Yonatan Beker

Corporate Communications Israel

Yonatan.Beker@tevapharm.com

Smadar Tabenkin-Ezer

Corporate Communications International Markets

Smadar.Tabenkin-Ezer01@teva.co.il

Leslie McGibbon

Corporate Communications Europe

Leslie.Mcgibbon@Tevaeu.com

At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:

alt text

Teva Code of Conduct

alt text

Supplier Code of Conduct

alt text

Social Impact Positions and Policies

alt text

All Corporate Governance & Policy Documents

Contact Us
Terms of Use

Data Privacy
PhV Privacy Notice

Teva api
Social Media Guidelines

Follow us

Copyright © 2019-20 Teva Pharmaceutical Industries Ltd.